|
US3357956A
(en)
|
1965-03-30 |
1967-12-12 |
Du Pont |
Polymeric 1, 3, 4-thiadiazoles and the process for their preparation
|
|
CH482394A
(de)
|
1966-09-14 |
1969-12-15 |
Shell Int Research |
Herbizides Mittel
|
|
FR2097737A5
(en)
|
1970-07-14 |
1972-03-03 |
Berlin Chemie Veb |
Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
|
|
DE2037257A1
(en)
|
1970-07-28 |
1972-02-03 |
Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt |
Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
|
|
GB1336575A
(en)
|
1970-12-22 |
1973-11-07 |
Ilford Ltd |
Seleno-semicarbazides
|
|
GB1272920A
(en)
|
1971-03-15 |
1972-05-03 |
Berlin Chemie Veb |
New thiosemicarbazides
|
|
DE2348808C3
(de)
*
|
1973-09-28 |
1980-10-09 |
Hoechst Ag, 6000 Frankfurt |
Formmasse auf Poly(oxymethylen)-Basis
|
|
US4012360A
(en)
|
1973-12-03 |
1977-03-15 |
Ciba-Geigy Corporation |
Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
|
|
JPS5519847Y2
(OSRAM)
|
1973-12-20 |
1980-05-12 |
|
|
|
JPS583499B2
(ja)
|
1975-07-28 |
1983-01-21 |
旭化成株式会社 |
アンテイカサレタ ポリウレタンソセイブツ
|
|
US4258151A
(en)
|
1979-01-26 |
1981-03-24 |
Sloan-Kettering Institute For Cancer Research |
Pentapeptide modified resin
|
|
US4515954A
(en)
|
1981-08-24 |
1985-05-07 |
American Cyanamid Company |
Metal chelates of anthracene-9,10-bis-carbonylhydrazones
|
|
US4490080A
(en)
|
1983-02-18 |
1984-12-25 |
Precision Industries, Inc. |
Hole cutting tool
|
|
JPS59201047A
(ja)
*
|
1983-04-30 |
1984-11-14 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀写真要素
|
|
EP0217519B1
(en)
|
1985-08-31 |
1992-02-05 |
FISONS plc |
5-membered heterocyclic ring angiotensin converting enzyme inhibitors
|
|
US4822777A
(en)
|
1987-02-27 |
1989-04-18 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition
|
|
JP2767241B2
(ja)
|
1987-04-15 |
1998-06-18 |
ロ−ム アンド ハ−ス コンパニ− |
殺虫性のｎ−（場合により置換された）−ｎ′−置換−ｎ，ｎ′−ジ置換ヒドラジン
|
|
US4826866A
(en)
|
1987-11-02 |
1989-05-02 |
A. H. Robins Company, Incorporated |
3-amino-5-methyl-1H-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics
|
|
DE68904905T2
(de)
|
1988-03-09 |
1993-07-22 |
Cis Bio Int |
Herstellung von als radiopharmazeutische produkte verwendbare nitruroverbindungen.
|
|
US6013836A
(en)
|
1992-02-28 |
2000-01-11 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
|
|
FR2697752B1
(fr)
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
|
US5814658A
(en)
|
1992-12-09 |
1998-09-29 |
Rhone-Poulenc Rorer S.A. |
Taxoids, their preparation and pharmaceutical compositions containing them
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
PT693924E
(pt)
|
1993-02-22 |
2004-09-30 |
American Biosciences |
Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5840746A
(en)
|
1993-06-24 |
1998-11-24 |
Merck Frosst Canada, Inc. |
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
|
|
US5523325A
(en)
|
1993-09-09 |
1996-06-04 |
Jacobson; Richard M. |
Amidrazones and their use as pesticides
|
|
WO1995033710A1
(de)
|
1994-06-03 |
1995-12-14 |
Basf Aktiengesellschaft |
Carbamoylcarbonsäurehydrazide und ihre verwendung zur bekämpfung von schadpilzen
|
|
CA2166676C
(en)
|
1995-01-09 |
2007-05-01 |
Yasuhisa Fujibayashi |
Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative
|
|
CA2232727C
(en)
|
1995-09-22 |
2002-03-26 |
Novo Nordisk A/S |
Novel variants of green fluorescent protein, gfp
|
|
US5739686A
(en)
|
1996-04-30 |
1998-04-14 |
Naughton; Michael J. |
Electrically insulating cantilever magnetometer with mutually isolated and integrated thermometry, background elimination and null detection
|
|
JPH1031282A
(ja)
*
|
1996-05-17 |
1998-02-03 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
US5753200A
(en)
|
1996-10-07 |
1998-05-19 |
Solvay Minerals, Inc. |
Sodium metabisulfite process
|
|
US6235787B1
(en)
|
1997-06-30 |
2001-05-22 |
Hoffmann-La Roche Inc. |
Hydrazine derivatives
|
|
GB9727524D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Synergistic antitumor composition containing a biologically active ureido compound
|
|
US20030195268A1
(en)
|
1998-05-20 |
2003-10-16 |
Freitag James W. |
Novel foaming compositions and methods for making and using the composition
|
|
TW479053B
(en)
|
1998-10-19 |
2002-03-11 |
Agro Kanesho Co Ltd |
Hydrazineoxoacetamide derivatives and pesticides
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
|
US6322303B1
(en)
|
2000-05-12 |
2001-11-27 |
David M. John |
Dunnage bag and method of making same
|
|
EP1164126A1
(de)
|
2000-06-16 |
2001-12-19 |
Basf Aktiengesellschaft |
Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
|
|
US6365745B1
(en)
|
2000-07-14 |
2002-04-02 |
Sumika Fine Chemicals Co., Ltd. |
Method for producing hydrazine derivative
|
|
US20020054869A1
(en)
|
2000-09-01 |
2002-05-09 |
Han-Mo Koo |
Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
|
|
WO2002059080A2
(en)
*
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
TWI231211B
(en)
|
2001-05-01 |
2005-04-21 |
Abbott Lab |
Compositions and methods for enhancing the bioavailability of pharmaceutical agents
|
|
WO2002094259A1
(en)
|
2001-05-03 |
2002-11-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
|
|
US6602907B1
(en)
|
2001-06-08 |
2003-08-05 |
University Of Central Florida |
Treatment of breast cancer
|
|
DE60213998T2
(de)
|
2001-06-20 |
2007-02-01 |
KURARAY CO., LTD, Kurashiki |
Verfahren zur herstellung von 2 oxocarbonsäureestern
|
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI332943B
(en)
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI252847B
(en)
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
|
US6924312B2
(en)
*
|
2001-07-10 |
2005-08-02 |
Synta Pharmaceuticals Corp. |
Taxol enhancer compounds
|
|
MXPA02010231A
(es)
|
2001-11-27 |
2004-12-13 |
Warner Lambert Co |
Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas.
|
|
MY133406A
(en)
|
2001-11-28 |
2007-11-30 |
Ipsen Pharma Sas |
5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
|
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
|
WO2003068054A2
(en)
|
2002-02-13 |
2003-08-21 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
PT2371392E
(pt)
|
2002-05-02 |
2015-10-07 |
Wyeth Holdings Llc |
Conjugados de derivado da caliqueamicina - transportador
|
|
EP1537105A2
(en)
|
2002-09-13 |
2005-06-08 |
Synta Pharmaceuticals Corporation |
Synthesis of indolizines
|
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
|
AU2006228035B2
(en)
|
2003-01-15 |
2010-02-18 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
|
|
MXPA05008335A
(es)
|
2003-02-11 |
2006-05-04 |
Vernalis Cambridge Ltd |
Compuestos de isoxazol como inhibidores de las proteinas de choque por calor.
|
|
KR100575251B1
(ko)
|
2003-03-03 |
2006-05-02 |
재단법인서울대학교산학협력재단 |
ｐ38／ＪＴＶ－1을 유효성분으로 하는 암 치료용 약학적조성물 및 암 치료용 약학적 조성물의 스크리닝 방법
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
US20070112044A1
(en)
|
2003-10-10 |
2007-05-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Thiadiazoline derivative
|
|
KR100544347B1
(ko)
|
2003-12-11 |
2006-01-23 |
한국생명공학연구원 |
디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
|
|
EP1730124A4
(en)
|
2004-03-26 |
2009-04-01 |
Amphora Discovery Corp |
Certain compounds based on triazole, compositions and applications thereof
|
|
WO2005097119A2
(en)
*
|
2004-04-06 |
2005-10-20 |
Semafore Pharmaceuticals, Inc. |
Pten inhibitors
|
|
HRP20131023T1
(hr)
|
2004-06-23 |
2013-12-06 |
Synta Pharmaceuticals Corp. |
Soli bis(tio-hidrazid amida) za lijeäśenje raka
|
|
JP2008505930A
(ja)
|
2004-07-09 |
2008-02-28 |
エラン ファーマシューティカルズ，インコーポレイテッド |
オキシム誘導体置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
|
|
US20060142393A1
(en)
|
2004-09-16 |
2006-06-29 |
Sherman Matthew L |
Bis(thio-hydrazide amides) for treatment of hyperplasia
|
|
CA2587598A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amides) for increasing hsp70 expression
|
|
US20060167106A1
(en)
*
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
CN101142198B
(zh)
|
2005-02-17 |
2012-10-31 |
辛塔制药公司 |
用于治疗疾病的异*唑坎布雷它斯丁衍生物
|
|
EP1877048A1
(en)
|
2005-04-15 |
2008-01-16 |
Synta Pharmaceuticals Corporation |
Combination cancer therapy with bis(thiohydrazide) amide compounds
|
|
WO2006113493A2
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of determining cancer prognosis via natural killer cell activity
|
|
WO2006113572A1
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of increasing natural killer cell activity for therapy
|
|
CA2607890A1
(en)
|
2005-05-16 |
2006-11-23 |
Synta Pharmaceuticals Corp. |
Synthesis of bis(thio-hydrazide amide) salts
|
|
CN101242820A
(zh)
|
2005-08-16 |
2008-08-13 |
辛塔制药公司 |
双（硫酰肼酰胺）调配物
|
|
AR057976A1
(es)
*
|
2005-08-29 |
2008-01-09 |
Boehringer Ingelheim Int |
Biarilos sustituidos y su uso como medicamentos.
|
|
SI22254A
(sl)
|
2006-04-13 |
2007-10-31 |
Univerza V Ljubljani Fakulteta Za Farmacijo |
NOVI ARILSULFONOHIDRAZIDNI INHIBITORJI ENCIMOV MurC IN MurD
|
|
US8318790B2
(en)
|
2006-05-25 |
2012-11-27 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
AU2007288334A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
|
EP2057117A2
(en)
|
2006-08-21 |
2009-05-13 |
Synta Pharmaceuticals Corporation |
Compounds for treating proliferative disorders
|
|
JP2010501564A
(ja)
|
2006-08-21 |
2010-01-21 |
シンタ ファーマシューティカルズ コーポレーション |
黒色腫を治療するためのビス（チオヒドラジドアミド）
|
|
JP2010501563A
(ja)
|
2006-08-21 |
2010-01-21 |
シンタ ファーマシューティカルズ コーポレーション |
増殖性障害を治療するための化合物
|
|
EP2063878A2
(en)
|
2006-08-21 |
2009-06-03 |
Synta Pharmaceuticals Corporation |
Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
|
|
WO2008024298A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for inhibiting angiogenesis
|
|
CA2661440A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
JP2010502616A
(ja)
|
2006-08-31 |
2010-01-28 |
シンタ ファーマシューティカルズ コーポレーション |
癌を治療するためのビス（チオヒドラジドアミド）の組み合わせ
|
|
US20080118562A1
(en)
|
2006-09-11 |
2008-05-22 |
Keizo Koya |
Bis(thiohydrazide amides) formulation
|
|
EP2059250A2
(en)
|
2006-09-14 |
2009-05-20 |
Synta Pharmaceuticals Corporation |
Compounds for the treatment of angiogenesis
|
|
TW200829543A
(en)
|
2006-09-15 |
2008-07-16 |
Synta Pharmaceuticals Corp |
Purification of bis(thiohydrazide amides)
|
|
EP2096111A1
(en)
*
|
2006-11-20 |
2009-09-02 |
Japan Tobacco Inc. |
Pyrazoles and use thereof as drugs
|
|
WO2008082579A1
(en)
|
2007-01-03 |
2008-07-10 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
WO2008136976A2
(en)
|
2007-04-30 |
2008-11-13 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2009020631A2
(en)
|
2007-08-07 |
2009-02-12 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2009064374A2
(en)
|
2007-11-09 |
2009-05-22 |
Synta Pharmaceuticals Corp. |
Oral formulations of bis(thiohydrazide amides)
|
|
EP2225201A2
(en)
|
2007-11-28 |
2010-09-08 |
Synta Pharmaceuticals Corp. |
Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
|
|
TW200940050A
(en)
|
2007-11-28 |
2009-10-01 |
Synta Pharmaceuticals Corp |
Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)
|
|
WO2009079338A1
(en)
|
2007-12-14 |
2009-06-25 |
Sciclone Pharmaceuticals, Inc. |
Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
|
|
WO2009105257A1
(en)
|
2008-02-21 |
2009-08-27 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8633323B2
(en)
|
2008-03-31 |
2014-01-21 |
Synta Pharmaceuticals Corp. |
Process for preparing bis(thiohydrazide amides)
|
|
WO2010002465A2
(en)
|
2008-07-01 |
2010-01-07 |
The Johns Hopkins University |
Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase
|
|
CA2741189A1
(en)
|
2008-10-22 |
2010-04-29 |
Synta Pharmaceuticals Corp. |
Transition metal complexes of bis[thiohydrazide amide] compounds
|
|
CA2740925A1
(en)
|
2008-10-22 |
2010-04-29 |
Synta Pharmaceuticals Corp. |
Transition metal complexes of a bis[thiohydrazide amide] compound
|
|
CA2745065A1
(en)
|
2008-12-01 |
2010-06-10 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2011069159A2
(en)
|
2009-12-04 |
2011-06-09 |
Synta Pharmaceuticals Corp. |
Bis[thiohydrazide amide] compounds for treating leukemia
|
|
US8815945B2
(en)
|
2010-04-20 |
2014-08-26 |
Masazumi Nagai |
Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
|
|
TWI403871B
(zh)
|
2010-10-25 |
2013-08-01 |
Ind Tech Res Inst |
伺服馬達驅動之回授切換裝置及方法
|
|
AU2012335105A1
(en)
|
2011-11-10 |
2014-06-19 |
Synta Pharmaceuticals Corp. |
Administration of a bis(thiohydrazide amide) compound for treating cancers
|
|
US20130149392A1
(en)
|
2011-12-12 |
2013-06-13 |
Synta Pharmaceuticals Corp. |
Method of treating non-small cell lung cancer with bis-(thiohydrazide)amide compounds
|